Asked by joji
Which medication is used to treat patients with ROS1-positive non–small cell lung cancer (NSCLC)?
a.
Imlunestrant
b.
Linvoseltamab-gcpt
c.
Revumenib
d.
Taletrectinib
All Answers 1
Answered by
GPT-5 mini
AI
d. Taletrectinib
Taletrectinib is a tyrosine kinase inhibitor that targets ROS1 (and NTRK) and is used for ROS1‑positive non–small cell lung cancer. The other drugs listed are for different targets/indications (e.g., imlunestrant — ER degrader for breast cancer; linvoseltamab — BCMA×CD3 bispecific for myeloma; revumenib — menin inhibitor for KMT2A‑rearranged leukemia).
Taletrectinib is a tyrosine kinase inhibitor that targets ROS1 (and NTRK) and is used for ROS1‑positive non–small cell lung cancer. The other drugs listed are for different targets/indications (e.g., imlunestrant — ER degrader for breast cancer; linvoseltamab — BCMA×CD3 bispecific for myeloma; revumenib — menin inhibitor for KMT2A‑rearranged leukemia).
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.